Phase-1 trial: Adenovirus COVID-19 vaccine found safe, induces immune responses
A phase-1 trial using a single dose of a vaccine (Ad5-nCoV) that uses a recombinant adenovirus type-5 vector that carries
Read More
Day: May 22, 2020
A phase-1 trial using a single dose of a vaccine (Ad5-nCoV) that uses a recombinant adenovirus type-5 vector that carries
Read More